This February, we’re heading to JFMN 2026 to connect with the francophone nuclear medicine community and discuss concrete ways to support radiopharmacy and hospital teams – from synthesis to quality control and dose management.

JFMN 2026 | Journée Francophone de Médecine Nucléaire

JFMN 2026 – practical information

Event: JFMN 2026 – Journée Francophone de Médecine Nucléaire
Date: 26-27 March 2026
Location: Congrès au Beffroi de Montrouge 2, Place Émile Cresp 92120 Montrouge
Meet Trasis: discuss synthesis automation, quality control, and dose management

Join us to discover how our solutions support radiopharmacy and hospital teams across the full workflow – from synthesis to quality control and dose management.

JFMN 2026

At JFMN, we will present

AllinOne family automated synthesis platforms, designed to support the routine production of PET and therapeutic radiopharmaceuticals with standardized and reproducible processes
QC1 and quality control solutions, developed to facilitate batch analysis and support compliance with pharmacopeial requirements in radiopharmaceutical production environments
Hospital solutions for radioprotection and automated dose dispensing, supporting safe preparation, shielding and administration of radiopharmaceuticals in nuclear medicine departments

Our colleagues Lou Gevaert, Jean-Michel Longtin, Simon Degueldre and Michel Bagoly will be on site to discuss your projects and operational challenges.

To schedule a meeting in advance, contact us at info@trasis.com.

Contact our experts

Discover our solutions

Until then, feel free to discover our solutions.

We look forward to connecting with the nuclear medicine community at JFMN 2026.

AllinOne automated synthesis platforms

AllinOne is an automated radiopharmaceutical synthesizer for R&D and routine production, with integrated HPLC-UV, traceability features, and support for 40+ tracers.

Widely used in radiopharmacy networks and research labs, the cassette-based AllinOne is designed to operate in both research and production environments, with semi-preparative radio/UV HPLC and reformulation capabilities to deliver fully integrated applications that minimize downtime.

Discover AllinOne

AllinOne automated radiopharmaceutical synthesis platform

QC1 automated radiopharmaceutical quality control system

QC1 automated radiopharmaceutical quality control

Designed to streamline your QC workflows, QC1 is a fully integrated, self-shielded system that brings safety, efficiency, and performance to a new level, and is compatible with European and US pharmacopeia.

With QC1, cut down on repetitive tasks and unlock your team’s full potential.

Discover QC1

SteriNow, for in-house and automated sterility testing

Sterinow® automates sterility test preparation using membrane filtration, directly on site, enhancing compliance, reducing operator exposure, and streamlining a critical quality control step in radiopharmaceutical production.

Sterinow® is a cassette-based solution that automates the preparation of sterility test samples using membrane filtration – with a process developed on Trasis’ synthesizer miniAllinOne – to simplify this critical QC step while ensuring regulatory compliance and improving operator safety and cost efficiency.

Discover SteriNow

SteriNow solution for sterile radiopharmacy workflows

FAQ – JFMN 2026

Will Trasis attend JFMN 2026?

Yes. Our team will be at JFMN 2026 to meet radiopharmacy and nuclear medicine professionals and discuss workflow challenges from synthesis to QC and dose management.

What can I discuss with Trasis at JFMN 2026?

Automated synthesis workflows, quality control organization, and operational solutions supporting safe preparation and dose dispensing.

How can I book a meeting with Trasis during JFMN 2026?

Use the contact button on this page and mention your topic and preferred time window.

Trasis at JFMN 2026: from synthesis to quality control and dose management

Related contents

Meet Trasis at Danish Radiochemistry Meeting 2026